当前位置：
X-MOL 学术
›
Clin. Pharmacokinet.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients?
Clinical Pharmacokinetics ( IF 4.5 ) Pub Date : 2022-07-23 , DOI: 10.1007/s40262-022-01154-x Robert Marcec 1 , Robert Likic 1, 2
中文翻译：
氟伏沙明剂量降低能否在不牺牲 COVID-19 患者疗效的情况下提高治疗依从性？
更新日期：2022-07-24
Clinical Pharmacokinetics ( IF 4.5 ) Pub Date : 2022-07-23 , DOI: 10.1007/s40262-022-01154-x Robert Marcec 1 , Robert Likic 1, 2
Affiliation
|
中文翻译：
氟伏沙明剂量降低能否在不牺牲 COVID-19 患者疗效的情况下提高治疗依从性？
京公网安备 11010802027423号